---
title: "Childhood plasma CXCL10, IL6 and IL33 associate with low FEV1 trajectory in UK birth cohort"
id: "medrxiv-8-biomarkers-of-ageing-and-lung-function-trajectory-a-multi-omics-study-in-a-uk"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-8-biomarkers-of-ageing-and-lung-function-trajectory-a-multi-omics-study-in-a-uk"
content_type: "clinical_feed_article"
specialty: "Pulmonology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1?rss=1"
published_at: "2026-11-04T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Childhood plasma CXCL10, IL6 and IL33 associate with low FEV1 trajectory in UK birth cohort
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-8-biomarkers-of-ageing-and-lung-function-trajectory-a-multi-omics-study-in-a-uk
- **Specialty:** [Pulmonology](https://medichelpline.com/clinical-feed/pulmonology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1?rss=1)
- **Published At:** 2026-11-04T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The Avon Longitudinal Study of Parents and Children (ALSPAC) cohort was analysed to link early-life molecular ageing and senescence markers with lung function trajectories between ages 8 and 30. - Outcomes were the two lowest of five previously derived FEV1 trajectories: **Persistently Low** and **Below Average**; trajectories were identified by latent profile analysis in prior work. - Exposures measured at ages 7–9 included nine blood-derived epigenetic age acceleration (EAA) metrics and thirteen senescence-associated plasma proteins; investigators used logistic regression to test associations with trajectory membership. - Plasma proteins CXCL10, IL6 and IL33 measured in childhood were associated with higher odds of membership in the Persistently Low FEV1 trajectory (OR 1.29 per SD for CXCL10 and IL6; OR 1.23 for IL33), while EAA measures showed little evidence of association. - The study team applied bidirectional one-sample Mendelian randomisation (MR) to probe causality; MR provided limited evidence that genetically predicted plasma proteins increase risk of low trajectories. - MR analyses suggested that genetically lower childhood FEV1 predicted higher plasma CXCL10 at ages 9 and 24 (reported beta coefficients in the source), implying possible causal direction from reduced lung function to elevated CXCL10. - Authors reported that childhood systemic inflammation markers (CXCL10, IL6, IL33) — not epigenetic age acceleration — may predict persistent low lung function into early adulthood and flagged IL33 for further therapeutic investigation. - The preprint status, the ALSPAC-specific data access restrictions, and the need for replication and mechanistic studies were noted as study limitations and next steps by the authors.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=9xLUCcBRKXlskurCM.YWLMKNJna7YSBeQqrSVVc3mFI-1793826597.315822-1.2.1.1-IqJaGlRLqVUSf7psN2yE_2gsvExQk8gruZzls43HSghgUDtVZEOBWVu.sHKZpCgU) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Biomarkers of ageing and lung function trajectory: a multi-omics study in a UK birth cohort [ View ORCID Profile](http://orcid.org/0000-0001-5543-5632)Jack S Grenville, [ View ORCID Profile](http://orcid.org/0000-0003-3284-3240)Paul D Yousefi, [ View ORCID Profile](http://orcid.org/0000-0002-5702-7728)Grace M Power, [ View ORCID Profile](http://orcid.org/0000-0003-0574-5071)Rebecca C Richmond, [ View ORCID Profile](http://orcid.org/0000-0003-4805-5759)James W Dodd doi: https://doi.org/10.64898/2026.11.03.26367166 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Jack S Grenville University of Bristol * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jack%2BS%2BGrenville%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Grenville%20JS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJack%2BS%2BGrenville%2B) * [ORCID record for Jack S Grenville](http://orcid.org/0000-0001-5543-5632 "Open in new tab") * For correspondence: jack.grenville@bristol.ac.uk Paul D Yousefi University of Bristol * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Paul%2BD%2BYousefi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yousefi%20PD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APaul%2BD%2BYousefi%2B) * [ORCID record for Paul D Yousefi](http://orcid.org/0000-0003-3284-3240 "Open in new tab") Grace M Power University of Bristol * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Grace%2BM%2BPower%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Power%20GM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGrace%2BM%2BPower%2B) * [ORCID record for Grace M Power](http://orcid.org/0000-0002-5702-7728 "Open in new tab") Rebecca C Richmond University of Bristol * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Rebecca%2BC%2BRichmond%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Richmond%20RC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARebecca%2BC%2BRichmond%2B) * [ORCID record for Rebecca C Richmond](http://orcid.org/0000-0003-0574-5071 "Open in new tab") James W Dodd University of Bristol * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=James%2BW%2BDodd%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Dodd%20JW&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJames%2BW%2BDodd%2B) * [ORCID record for James W Dodd](http://orcid.org/0000-0003-4805-5759 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1338068/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1338068/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1338068/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1338068/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1338068/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1338068/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract BACKGROUND: Accelerated biological ageing and cellular senescence are pathogenically implicated in COPD and may represent therapeutic targets. Adverse early-life lung function trajectories offer opportunities to prevent COPD but their relationship with epigenetic and proteomic ageing biomarkers remains unexplored. We investigated using conventional epidemiological and Mendelian randomisation (MR) methods. METHODS: Outcomes were the two lowest of five FEV1 trajectories (Persistently Low and Below Average) previously identified using latent profile analysis (ages 8-30) in the Avon Longitudinal Study of Parents and Children. Exposures included nine measures of blood-derived epigenetic age acceleration (EAA) and thirteen senescence-associated plasma proteins (ages 7-9). We used logistic regression to estimate odds of lower trajectory membership by exposure and bidirectional one-sample MR to investigate causation. RESULTS: Higher plasma CXCL10 (OR 1.29 per SD; 95% CI 1.03, 1.57), IL6 (OR 1.29; 1.03, 1.57) and IL33 (OR 1.23; 1.04, 1.44) were associated with Persistently Low lung function trajectory, with little evidence for associations between EAA and lower trajectories. MR provided little evidence that genetically predicted plasma proteins influenced risk of lower trajectories, but lower genetically proxied childhood FEV1 predicted higher plasma CXCL10 at ages 9 (β -0.34; -0.65, -0.03) and 24 (β -0.38; -0.67, -0.08). INTERPRETATION: Childhood plasma CXCL10, IL6 and IL33, but not EAA, predict low lung function trajectory into early adulthood. Lower childhood lung function may causally relate to persistently increased plasma CXCL10. Future research should investigate IL33 as a potential therapeutic target in low lung function trajectory and persistent systemic inflammation as a mechanism for associated multimorbidity. ### Competing Interest Statement J.W.D. has received support with attending conferences from Roche and Sanofi. J.S.G., P.Y., G.M.P. and R.C.R. have no conflicts of interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The ALSPAC Ethics and Law Committee gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The informed consent obtained from ALSPAC (Avon Longitudinal Study of Parents and Children) participants does not allow the data to be made available through any third party maintained public repository. Supporting data are available from ALSPAC on request under the approved proposal number, B4854. Full instructions for applying for data access can be found here: http://www.bristol.ac.uk/alspac/researchers/access/. The ALSPAC study website contains details of all available data (http://www.bristol.ac.uk/alspac/researchers/our-data/). ## Funder Information Declared Medical Research Council, MR/Z505924/1, G0401540/73080, MR/M022501/1, MC_UU_00032/1, MC_UU_00032/4 NIHR Bristol Biomedical Research Centre, https://ror.org/02mtt1z51, NIHR 203315 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.03.26367173v1 "Career development awards are associated with lower career-long research attrition risk in Veterans Affairs investigators.")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.03.26367143v1 "Periodontitis and Associated Factors Among Dental Outpatients at Tertiary Hospitals in Dhaka") Posted November 04, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/04/2026.11.03.26367166.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.11.03.26367166v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/04/2026.11.03.26367166.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Biomarkers of ageing and lung function trajectory: a multi-omics study in a UK birth cohort Jack S Grenville, Paul D Yousefi, Grace M Power, Rebecca C Richmond, James W Dodd medRxiv 2026.11.03.26367166; doi: https://doi.org/10.64898/2026.11.03.26367166 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.03.26367166v1%26text%3DBiomarkers%2520of%2520ageing%2520and%2520lung%2520function%2520trajectory%253A%2520a%2520multi-omics%2520study%2520in%2520a%2520UK%2520birth%2520cohort "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.03.26367166v1%26t%3DBiomarkers%2520of%2520ageing%2520and%2520lung%2520function%2520trajectory%253A%2520a%2520multi-omics%2520study%2520in%2520a%2520UK%2520birth%2520cohort "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.03.26367166v1%26title%3DBiomarkers%2520of%2520ageing%2520and%2520lung%2520function%2520trajectory%253A%2520a%2520multi-omics%2520study%2520in%2520a%2520UK%2520birth%2520cohort%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.03.26367166v1%26title%3DBiomarkers%2520of%2520ageing%2520and%2520lung%2520function%2520trajectory%253A%2520a%2520multi-omics%2520study%2520in%2520a%2520UK%2520birth%2520cohort "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.03.26367166) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.03.26367166v1&count=horizontal&via=&text=Biomarkers%20of%20ageing%20and%20lung%20function%20trajectory%3A%20a%20multi-omics%20study%20in%20a%20UK%20birth%20cohort&counturl=www.medrxiv.org/content/10.64898/2026.11.03.26367166v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (638) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (917) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (349) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4986) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (494) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (427) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (675) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1688) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16239) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1241) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7267) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (751) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1093) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5277) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1465) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1829) * [Hematology](https://www.medrxiv.org/collection/hematology) (599) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1379) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16477) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1200) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (699) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (750) * [Neurology](https://www.medrxiv.org/collection/neurology) (7572) * [Nursing](https://www.medrxiv.org/collection/nursing) (377) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1126) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1295) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1038) * [Oncology](https://www.medrxiv.org/collection/oncology) (3739) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1090) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (407) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (465) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (500) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (720) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1854) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (754) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (785) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6114) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9974) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2525) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1513) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1268) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (658) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (801) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (595) * [Surgery](https://www.medrxiv.org/collection/surgery) (801) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (318) * [Urology](https://www.medrxiv.org/collection/urology) (307) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered
## Related Clinical Research

- [Physical activity intensity linked to lower self-reported emphysema in older US adults (NHANES ana](https://medichelpline.com/clinical-feed/plos-one-5-association-between-physical-activity-intensity-and-self-reported-emphysema-a.md)
- [Single-cell lung eQTLs link alveolar type 2 cells to COPD lung-function loci](https://medichelpline.com/clinical-feed/medrxiv-23-single-cell-lung-eqtl-colocalization-implicates-alveolar-epithelial-regulatory.md)
- [Network-guided discovery of candidate biomarkers for COPD comorbidities using deep learning](https://medichelpline.com/clinical-feed/biorxiv-19-network-guided-identification-of-candidate-biomarkers-for-copd-associated.md)
- [Triglyceride-Glucose (TyG) Index and Mortality in Non-Diabetic Fibrotic Lung Disease on Antifibrot](https://medichelpline.com/clinical-feed/plos-one-1-association-between-triglyceride-glucose-index-and-all-cause-mortality-in-non.md)
- [Tracheal Eccentricity on CT Predicts Morbidity and Mortality in COPD](https://medichelpline.com/clinical-feed/medrxiv-12-tracheal-eccentricity-is-associated-with-respiratory-morbidity-and-mortality-in.md)

## Navigation
- [← Back to Pulmonology Feed](https://medichelpline.com/clinical-feed/pulmonology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.